Orient Pharma Co., Ltd. (4166) Stock Price & Analysis
4166 Stock Chart & Stats
- Day’s Range
- TWD 22.00 - TWD 23.25
- 52-Week Range
- TWD 22.00 - TWD 29.60
- Previous Close
- TWD 22.70
- Volume
- N/A
- Average Volume (3M)
- 65.48K
- Market Cap
- TWD 5.35B
- Enterprise Value
- TWD 5.94B
- Total Cash (Recent Filing)
- TWD 585.05M
- Total Debt (Recent Filing)
- TWD 189.61M
- Price to Earnings (P/E)
- 22.2
- Beta
- 0.33
- Next Earnings
- Nov 17, 2026 (Est.)
- EPS Estimate
- N/A
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
4166 FAQ
What was Orient Pharma Co., Ltd.’s price range in the past 12 months?
What is Orient Pharma Co., Ltd.’s market cap?
When is Orient Pharma Co., Ltd.’s upcoming earnings report date?
How were Orient Pharma Co., Ltd.’s earnings last quarter?
Is Orient Pharma Co., Ltd. overvalued?
Does Orient Pharma Co., Ltd. pay dividends?
What is Orient Pharma Co., Ltd.’s EPS estimate?
How many shares outstanding does Orient Pharma Co., Ltd. have?
What happened to Orient Pharma Co., Ltd.’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Orient Pharma Co., Ltd.?
What is the TipRanks Smart Score and how is it calculated?
Company Description
Orient Pharma Co., Ltd.
Orient Pharma Co., Ltd., established in Taipei, Taiwan, in 2008, is a global pharmaceutical company engaged in the research, development, production, and sales of medicinal products. Its extensive pipeline addresses diverse therapeutic areas, including psychiatric disorders such as anti-psychotics and psychostimulants, neurological conditions like Parkinson's and Alzheimer's diseases, and treatments for sialorrhea, tuberculosis, and attention deficit hyperactivity disorder (ADHD). Beyond its drug portfolio, the company is also at the forefront of developing advanced drug delivery technologies, featuring multi-stage controlled release systems, transdermal patches, orally disintegrating tablets, sustained-release formulations, and microgranule technology.
- Sector
- General
- Industry
- Medical - Pharmaceuticals
- CEO
- Chun-Tong Huang
- Employees
- 173
- Website
- www.oppharma.com
- Address
- No. 368, Fu Hsing South Road, Taipei, TP, 106, TW
Orient Pharma Co., Ltd. (4166) Earnings & Revenues
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 7 | 0 | 15 |
| Technical Analysis | 7 | 0 | 3 |
| Moving Averages | 0 | 0 | 12 |
